Assessing Risk of Venous Thromboembolism in the Patient With Cancer
2009; Lippincott Williams & Wilkins; Volume: 27; Issue: 29 Linguagem: Inglês
10.1200/jco.2009.22.3271
ISSN1527-7755
AutoresAlok A. Khorana, Gregory C. Connolly,
Tópico(s)Inflammatory Biomarkers in Disease Prognosis
ResumoPatients with cancer are increasingly at risk for venous thromboembolism (VTE). Rates of VTE, however, vary markedly among patients with cancer.
Referência(s)